News
Hovione Announces Partnership to Support Manufacturing of Antiviral Veklury for COVID-19
Hovione announced the signing of a partnership agreement with Ligand to significantly ramp up the production output of Captisol®. Captisol®, a Ligand product, is a...
News
Agilex Biolabs Develops World’s Most Accurate Cannabinoid Assay
Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
The assay is...
News
Lantern Pharma Fox Chase Cancer Center Collaborate on Advancing the Development of LP-184 in Pancreatic Cancer
Lantern Pharma , a clinical-stage biopharma company using its proprietary RADR® artificial intelligence ("A.I.") platform to improve drug discovery & development and identify patients who...
News
Serum Institute of India starts manufacturing Codagenix’s nasal COVID-19 vaccine
Serum Institute of India has started manufacturing COVID-19 vaccine candidate developed by Codagenix Inc, the US biotech firm said in a statement. Dubbed as CDX-005,...
News
Oxgene introduces TESSA technology for plasmid-free manufacturing system for Adeno-associated virus
Oxgene, a biotechnology company designing and developing scalable gene therapy technologies, has announced the launch of its scalable, plasmid-free manufacturing system for Adeno-associated virus (AAV)....
Clinical Trials
Bharat Biotech to collaborate with Washington University School of Medicine on COVID-19 nasal vaccine
Vaccine maker Bharat Biotech has entered into an agreement with Washington University School of Medicine in St. Louis as part of which it will conduct...
Clinical Trials
I-Mab receives China NMPA clearance to begin phase 1 trial of lemzoparlimab in relapsed/refractory advanced lymphoma
I-Mab, a clinical stage biopharmaceutical company, announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has cleared the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.